Selected Grants
A Pragmatic Phase II Trial of Chemotherapy +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Clinical TrialPrincipal Investigator · Awarded by Indiana University · 2025 - 2030I-SPY 2 Trial: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Clinical TrialPrincipal Investigator · Awarded by Quantum Leap Healthcare Collaborative · 2025 - 2030A single shot therapy will accelerate the elimination of breast cancer
ResearchResearch Professional · Awarded by United States Army Medical Research Acquisition Activity · 2024 - 2028Cardiovascular Impact of Near-complete Estrogen Deprivation for Breast Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2027Predicting cancer treatment-related cardiotoxicity by imaging cardiac mechanical stiffness
ResearchPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2025 - 2026NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
ResearchPrincipal Investigator · Awarded by NRG Oncology · 2023 - 2026External Relationships
- Accord BioPharma
- Cancer Expert Now
- Exact Sciences
- RTI International
- WebMD/Medscape
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.